Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Conditions
Interventions
Intervention1: INSULIN: HUMAN ACTRAPID, from the total dose of short acting insulin (Human Actrapid) required for the patient (per day) half of it is diluted with 1 ml sterile water and injected into
Sponsors
PRASSANNA RAJU
Eligibility
Inclusion criteria
Inclusion criteria: 1) Diabetic foot ulcer with Grade 2 of Wagner Meggit classification 2) Age More than 18 years
Exclusion criteria
Exclusion criteria: 1) Patient in sepsis 2) Immunocompromised patient - HIV, HBsAg, HCV, and another disease that requires steroids as treatment. 3) Patient with renal failure 4) Patient with Severe Anemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage reduction of wound size in Group A is 79.7 % and the Percentage reduction in Group B is 40.84 %Timepoint: The rate of regression of wound size, slough reduction, and presence of granulation tissue will be measured in day one and 7th, 14th and 21st day | — |
Secondary
| Measure | Time frame |
|---|---|
| To identify the factors associated with wound healing among the patients with diabetic foot ulcer.Timepoint: The rate of regression of wound size, slough reduction, & presence of granulation tissue will be measured in day one & 7th, 14th & 21st day | — |
Countries
India
Contacts
Public ContactPRASSANNA RAJU
PONDICHERRY INSTITUTE OF MEDICAL SCEINCES
Outcome results
None listed